300006SZSE

Announcement on Obtaining Drug Registration Certificate

Lai Mei Pharmaceuticals Co., Ltd.··2 pages

✨ AI Summary

Chongqing R&M Pharmaceutical Co., Ltd. announced it has received a Drug Registration Certificate from the NMPA for its Inhaled N-acetylcysteine Solution (3ml:0.3g). This approval is expected to expand the company's product line and enhance competitiveness. The company acknowledges potential market uncertainties due to policy, procurement, and environmental changes.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Chongqing R&M Pharmaceutical Co., Ltd.

Announcement on Obtaining Drug Registration Certificate

The Company and all members of the Board of Directors guarantee the authenticity, accuracy, and completeness of the disclosed information, and that there are no false records, misleading statements, or material omissions.

Recently, Chongqing R&M Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") received the "Drug Registration Certificate" for Inhaled N-acetylcysteine Solution (3ml:0.3g) issued by the National Medical Products Administration. The relevant matters are hereby announced as follows:

I. Basic Information of the Drug

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.